Researchers discover new way to deliver DNA-based therapies for diseases
Polymers could be used to create less expensive gene therapies or vaccines for diseases
Reineke Group and Frontiera Group, University of Minnesota
The above image shows cells illuminated by quinine (fluorescent blue) and green fluorescent protein. This allows the U of M researchers to for the first time observe how polymers interact with human cells when delivering medicines. The discovery could be used in advancing DNA and RNA-based treatments such as gene therapy and vaccines.
Newswise MINNEAPOLIS / ST. PAUL (12/18/2020) – University of Minnesota Twin Cities researchers in the Department of Chemistry have created a new polymer to deliver DNA and RNA-based therapies for diseases. For the first time in the industry, the researchers were able to see exactly how polymers interact with human cells when delivering medicines into the body. This discovery opens the door for more widespread use of polymers in
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
BioSig’s Division NeuroClear Technologies Signs a Research Agreement with the University of .
BioSig Technologies, Inc.December 18, 2020 GMT
Westport, CT, Dec. 18, 2020 (GLOBE NEWSWIRE) BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced that the Company and its NeuroClear Technologies division signed a new research agreement with the University of Minnesota.
Under the terms of the agreement, the Company intends to launch a program to develop novel therapies to treat sympathetic nervous system disease. Due to launch in Q4 2020, the program studies are expected to form a foundation for developing a new platform technology to address disorders of the
Created: December 18, 2020 03:28 PM
While many have felt isolated during the pandemic, that loneliness may be magnified during the holiday season.
But health experts say there are steps you can take to help avoid the holiday blues.
Many of us have canceled trips, said no to a party or are making the tough decision to not see loved ones over the next couple weeks. We have some virtual game nights planned, said Jennifer Lindquist, who lives in Golden Valley. Decided not to go home and see family this year, not risk it.
For some, it s creating a time of isolation. But even before the pandemic, loneliness was a problem. A recent survey by Cigna of 20,000 U.S. adults found more than half admitted to feeling lonely.
E-Mail
University of Minnesota Twin Cities researchers in the Department of Chemistry have created a new polymer to deliver DNA and RNA-based therapies for diseases. For the first time in the industry, the researchers were able to see exactly how polymers interact with human cells when delivering medicines into the body. This discovery opens the door for more widespread use of polymers in applications like gene therapy and vaccine development.
The research is published in the
Proceedings of the National Academy of Sciences (
PNAS), a peer-reviewed multidisciplinary scientific journal.
Gene therapy involves altering the genes inside the body s cells to treat or cure diseases. It requires a carrier that packages the DNA to deliver it into the cell oftentimes, a virus is used as a carrier. Packaging of nucleic acids is also used in vaccines, such as the recently developed messenger RNA (mRNA) COVID-19 vaccine, which is enclosed in a lipid.